Westlake
Valuation each multiple against its own 5-year range
Vs. peers Specialty Chemicals
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Westlake (WLK) | 7.41B | -16.70 | 0.86 | 3.66% |
| Linde (LIN) | 230.84B | 33.39 | 5.86 | 1.25% |
| Ecolab (ECL) | 82.65B | 40.10 | 7.93 | 0.99% |
| Sherwin-Williams (SHW) | 82.08B | 31.25 | 20.64 | 0.94% |
| Air Products & Chemicals (APD) | 66.16B | 124.31 | 4.63 | 2.43% |
| PPG Industries (PPG) | 25.87B | 16.71 | 3.05 | 2.45% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 38.2% below Morningstar's fair value estimate.
Fair value
Westlake Corp receives a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 21% discount to our quantitative fair value estimate of $80.08 per share; however, some caution is warranted due to this estimate's medium uncertainty rating.
The company's valuation metrics increase our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 106.7%, which falls in the top 30% globally. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are cheap.
The firm's balance sheet is an additional encouraging factor. Leverage can enable a company to invest in growth, potentially boosting shareholder value more than equity financing alone. The firm's EBITDA/interest coverage ratio of 3.4, for example, falls in the bottom 30% globally. Although the firm's ability to cover interest payments with EBITDA is limited, shares could sharply rebound if economic circumstances change or recent investments reduce fears of default. This characteristic further promotes our favorable price/fair value ratio.
Economic moat
With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Westlake discussion 0 comments